NDC 80425-0303-01 - Buspirone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0303
- Requested NDC
- 80425-0303-01
- Package NDCs from labels
- 80425-0303-1, 80425-0303-2, 80425-0303-3, 80425-0303-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buspirone Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0303-1 | Buspirone Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 80425-0303-2 | Buspirone Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 80425-0303-3 | Buspirone Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0303 | BUSPIRONE HYDROCHLORIDE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f8afd9b8-0885-2f0c-e053-6294a90a9c57.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0303-1 | EA - Each | 80425-0303 | f4913649-e1ba-42f9-8427-a607b54d7ddf | 1 | 2023-06-06 |
| 80425-0303-2 | EA - Each | 80425-0303 | 37cb4f00-cf48-48e7-87f2-e17af97a0001 | 1 | 2023-06-06 |
| 80425-0303-3 | EA - Each | 80425-0303 | 9453aa87-69d6-4b8b-9098-5a9978f87ac7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 540e9b7e-09ff-2cca-e054-00144ff8d46c | 2024-07-09 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 267d8897-90dd-4f8a-bbd8-8aa4e47c2905 | 2024-07-09 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | db32a7ec-5b50-4305-8952-df22e7e871e2 | 2024-07-09 | Warnings, Adverse reactions | 866083 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | APNAR PHARMA LP | 3c115eea-9dbc-4e2c-9d79-42e3388fde5a | 2024-06-17 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | American Health Packaging | e80d83a6-7c2a-478e-bdf1-c481824fc301 | 2024-06-07 | Warnings, Adverse reactions | 866083 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | 19afb386-72a5-c97e-e063-6294a90adaea | 2024-05-30 | Warnings, Adverse reactions | ANDA210907 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | cff1c7b2-4edb-4b5a-9626-2f7b8671b015 | 2024-05-22 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE | Boswell Pharmacy Services d/b/a BPS Wholesale | 18e90d65-4a3a-864e-e063-6294a90ae99d | 2024-05-15 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 2a25a718-306f-403e-9928-cae30bc52f12 | 2024-05-06 | Warnings, Adverse reactions | ANDA210907 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | a2867dde-e5dd-4cc8-84d0-59240626868a | 2024-04-05 | Warnings, Adverse reactions | ANDA210907 866090 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | eab53fff-c052-4466-a673-3d68aab98c27 | 2024-04-05 | Warnings, Adverse reactions | ANDA210907 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 2a8b3b75-5d93-4a9e-a583-49ccddd65650 | 2024-04-03 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | a738c103-134a-401f-b14c-49a599130b8d | 2024-04-03 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 5fa0720f-e236-4b8b-a0c0-6f48037c76b3 | 2024-04-03 | Warnings, Adverse reactions | ANDA210907 866018 207LT9J9OC |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | Proficient Rx LP | 75b1ae3f-e926-4555-a0e9-50323fc66cb2 | 2024-02-01 | Warnings, Adverse reactions | 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Proficient Rx LP | 1886b672-4b88-4b49-ae6a-d2ba2f452e44 | 2024-01-01 | Warnings, Adverse reactions | ANDA210907 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | bce96786-4d9a-460e-8d92-9908ea2af07a | 2023-12-27 | Warnings, Adverse reactions | ANDA210907 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | a6bdf140-075e-445e-a62d-633a4b97f3a8 | 2023-12-22 | Warnings, Adverse reactions | ANDA210907 29300-246 866083 866090 866094 866018 ef78a61a-865b-447a-9324-3044e41db506 a6bdf140-075e-445e-a62d-633a4b97f3a8 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | b07c0a91-892c-47f5-819e-a128e0ef1ed7 | 2023-12-15 | Warnings, Adverse reactions | 207LT9J9OC |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 55e32128-711d-4e95-b58b-e86e0afa4983 | 2023-12-05 | Warnings, Adverse reactions | 207LT9J9OC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.